全文获取类型
收费全文 | 66272篇 |
免费 | 5837篇 |
国内免费 | 2454篇 |
专业分类
耳鼻咽喉 | 129篇 |
儿科学 | 2366篇 |
妇产科学 | 202篇 |
基础医学 | 4106篇 |
口腔科学 | 408篇 |
临床医学 | 10549篇 |
内科学 | 12453篇 |
皮肤病学 | 329篇 |
神经病学 | 2789篇 |
特种医学 | 2608篇 |
外国民族医学 | 6篇 |
外科学 | 10862篇 |
综合类 | 11995篇 |
现状与发展 | 13篇 |
一般理论 | 1篇 |
预防医学 | 2779篇 |
眼科学 | 918篇 |
药学 | 5601篇 |
77篇 | |
中国医学 | 3772篇 |
肿瘤学 | 2600篇 |
出版年
2024年 | 180篇 |
2023年 | 1449篇 |
2022年 | 1976篇 |
2021年 | 4001篇 |
2020年 | 3560篇 |
2019年 | 2738篇 |
2018年 | 2557篇 |
2017年 | 2783篇 |
2016年 | 2701篇 |
2015年 | 2554篇 |
2014年 | 4519篇 |
2013年 | 5036篇 |
2012年 | 3861篇 |
2011年 | 4215篇 |
2010年 | 3256篇 |
2009年 | 2992篇 |
2008年 | 2943篇 |
2007年 | 3108篇 |
2006年 | 2801篇 |
2005年 | 2539篇 |
2004年 | 2264篇 |
2003年 | 2184篇 |
2002年 | 1356篇 |
2001年 | 1217篇 |
2000年 | 1075篇 |
1999年 | 834篇 |
1998年 | 740篇 |
1997年 | 689篇 |
1996年 | 611篇 |
1995年 | 528篇 |
1994年 | 442篇 |
1993年 | 316篇 |
1992年 | 312篇 |
1991年 | 260篇 |
1990年 | 174篇 |
1989年 | 212篇 |
1988年 | 195篇 |
1987年 | 149篇 |
1986年 | 137篇 |
1985年 | 233篇 |
1984年 | 152篇 |
1983年 | 111篇 |
1982年 | 133篇 |
1981年 | 121篇 |
1980年 | 78篇 |
1979年 | 73篇 |
1978年 | 59篇 |
1977年 | 46篇 |
1976年 | 40篇 |
1975年 | 26篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
Rafiye Ciftciler Haluk Demiroglu Yahya Buyukasık Elifcan Aladag Salih Aksu Ibrahim C. Haznedaroglu Nilgun Sayınalp Osman Ozcebe Umit Yavuz Malkan Hakan Goker 《Clinical Lymphoma, Myeloma & Leukemia》2019,19(3):177-182
Background
Refractory acute myeloid leukemia (AML) includes AML includes failure of disease to respond to standard induction chemotherapy, relapse within 6 months after first CR, and 2 or more relapses. The outcome of these patients is usually very poor; only a small proportion can be rescued by allogenic hematopoietic stem-cell transplantation (allo-HSCT). The aim of this study was to evaluate the efficacy and feasibility of allo-HSCT in patients with refractory AML.Patients and Methods
We retrospectively analyzed the clinical outcome of 91 patients who were diagnosed with treatment-refractory AML at Hacettepe University Hospital between January 2002 and June 2018. Patients' disease status included refractory AML, defined as failure to respond to standard induction chemotherapy and relapse within 6 months after first complete remission.Results
The median follow-up was 12 months (range, 0.5-184 months) for the entire group. Kaplan-Meier estimates of the 3-year overall survival for patients who underwent allo-HSCT and patients who received only salvage chemotherapy were 67% and 12%, respectively. Additionally, the Kaplan-Meier estimates of 5-year overall survival for patients who underwent allo-HSCT and patients who received only salvage chemotherapy were 44% and 4%, respectively (P < .001). Complete remission was obtained in 25 patients (83.3%) who underwent allo-HSCT; however, the disease of only 3 patients (3.8%) exhibited complete response after salvage chemotherapy.Conclusion
Allo-HSCT is still the best-known treatment option with curative potential in patients with treatment-refractory AML. Therefore, all efforts should be made in an attempt to find a suitable matched donor in order to perform allo-HSCT. 相似文献32.
Gautam Chakrabarty Mayank Vashishtha Daniel Leeder 《Journal of Clinical Orthopaedics and Trauma》2015,6(2):108-112
Polyethylene (PE) has been used extensively in knee arthroplasty since the mid 20th century. Progress in material manufacturing and processing has led to newer polyethylenes over last few decades with different material properties. It has been established that PE wear in knee arthroplasty causes particle induced osteolysis which is the main reason for late failure and requires revision surgery. Although there are various causes of wear, the properties of PE have long been a matter of investigation as a contributory factor. The advent of newer highly cross linked PE has been shown to improve wear rates in hip arthroplasty but the benefits have not been shown to be of the same degree in knee arthroplasty. The laboratory and clinical studies so far are limited and slightly conflicting in their conclusions. The risks of using highly cross linked PE in knee arthroplasty include tibial post fracture, disruption of locking mechanism, liner fracture which can lead to increased wear and osteolysis. The current evidence suggests that highly cross linked polyethylenes should be used with caution and only considered in younger active patients. The results of a recently completed randomized trial to compare the conventional with high molecular weight PE in knee arthroplasty are awaited. 相似文献
33.
34.
Qiaojie Wang Karan Goswami Noam Shohat Arash Aalirezaie Jorge Manrique Javad Parvizi 《The Journal of arthroplasty》2019,34(5):947-953
Background
Whether prolonged operative time is an independent risk factor for subsequent surgical site infection (SSI) and periprosthetic joint infection (PJI) following total joint arthroplasty (TJA) remains a clinically significant and underexplored issue. The aim of this study is to investigate the association between operative time and the risk of subsequent SSI and PJI in patients undergoing primary TJA.Methods
We retrospectively reviewed 17,342 primary unilateral total knee arthroplasty and total hip arthroplasty performed at a single institution between 2005 and 2016, with a minimum follow-up of 1 year. A multivariate logistic regression model was conducted to identify the association between operative time and the development of SSI within 90 days and PJI within 1 year.Results
Overall, the incidence of 90-day SSI and 1-year PJI was 1.2% and 0.8%, respectively. Patients with an operative time of >90 minutes had a significantly higher incidence of SSI and PJI (2.1% and 1.4%, respectively) compared to cases lasting between 60 and 90 minutes (1.1% and 0.7%), and those lasting ≤60 minutes (0.9% and 0.7%, P < .01). In the multivariate model, the risk for infection increased by an odds ratio of 1.346 (95% confidential interval 1.114-1.627) for 90-day SSI and 1.253 (95% confidential interval 1.060-1.481) for 1-year PJI for each 20-minute increase in operative time.Conclusion
In patients undergoing primary TJA, each 20-minute increase in operative time was associated with nearly a 25% increased risk of subsequent PJI. We advocate that surgeons pay close attention to this underappreciated risk factor while maintaining safe operative practices, which minimize unnecessary steps and wasted time in the operating room. 相似文献35.
目的探究创伤骨科护理管理中疼痛管理的应用价值。方法 82例患者选取于2017年6月-2018年6月,所有患者均来源于本院骨科收治的住院患者,数字表为患者分组原则,常规组41例,疼痛组41例,分别予以常规护理、常规护理+疼痛管理,比较满意度、疼痛评分及平均住院时间。结果疼痛组满意度92.68%比常规组73.17%高,差异具有统计学意义(χ^2=5.513,P <0.05),患者干预后的疼痛评分低于常规组,平均住院时间短于常规组,差异存在统计学意义(P<0.05)。结论疼痛管理用于创伤骨科护理管理中,患者疼痛明显减轻,患者满意度高,缩短了患者的平均住院时间。 相似文献
36.
37.
《Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society》2020,28(11):1412-1426
38.
39.
40.
急性心肌梗死患者D二聚体质量浓度与远期预后的关系 《首都医科大学学报》2022,43(2):173-177
目的 探讨急性心肌梗死(acute myocardial infarction,AMI)患者D二聚体(D-dimer)质量浓度与病情严重程度和远期心源性死亡的关系。方法 选取2013年1月至2020年1月收入首都医科大学附属北京友谊医院的AMI患者3 990例,根据D-dimer质量浓度分为3组:≤0.50 mg/L、0.51~0.80 mg/L、≥0.81 mg/L,平均随访时间为2.1 (1.0~4.0) 年。应用Cox比例风险回归模型评估D-dimer对心源性死亡的影响。结果 D-dimer≥0.81 mg/L组患者年龄较大、女性居多、体质量指数较低,既往合并高血压、糖尿病者较多,3支病变较为多见,住院期间肾小球滤过率较低,N末端B型利钠肽原峰值明显升高,左室射血分数<50%患者比例明显升高。D-dimer≥0.81 mg/L组患者在随访期间累计心源性病死率(18.7%)高于D-dimer≤0.50 mg/L组(2.3%)和D-dimer 0.51~0.80 mg/L组(6.1%),且校正其他危险因素后,D-dimer能独立预测AMI患者的心源性死亡(HR=1.71,95%CI:1.34~2.18,P<0.001)。结论 D-dimer能反映AMI患者病情的严重程度,且D-dimer升高可在一定程度上预测AMI患者远期心源性死亡事件发生率升高。 相似文献